# Precision Neuroscience

> A minimally invasive cortical interface for people with paralysis.

## Why it is interesting

Precision is moving brain-computer interfaces toward broader clinical use with an FDA-cleared electrode array and experience from more than 100 patient procedures.

## Profile

- **Latest funding:** Series D — $250M (September 24, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $250M
- **Stage:** growth
- **Status:** private
- **Industries:** N/A
- **Coverage:** stub
- **Last updated:** 2026-09-25
- **Latest funding investors:** Pershing Square Inc., Ackman Oxman Institute, Undisclosed life-sciences investment fund, B Capital, ARK Invest, Mubadala Capital

## Funding history

- Series D · $250M · September 24, 2026
  Source: https://www.biospace.com/press-releases/precision-neuroscience-closes-oversubscribed-250m-series-d-led-by-pershing-square-inc-the-ackman-oxman-institute-and-a-leading-life-sciences-investment-fund

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** September 25, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/precision-neuroscience